<<

Archives of and Respiratory Medicine ISSN: 2639-362X Volume 2, Issue 1, 2019, PP: 07-10 A Case of Lymphangioleiomyomatosis and Review of Literature Dikshya Sharma1*, Bindumudduluru2, Michel Chalhoub3 1Fellow, Department of pulmonary and critical care medicine, Staten island university hospital, Staten island, New York. 2Staten island university hospital, Staten island, New York. 3Attending, Department of pulmonary and critical care medicine, Staten island university hospital, Staten island, New York. [email protected] *Corresponding Author: Dikshya Sharma, Fellow, Department of pulmonary and critical care medicine, Staten island university hospital, Staten island, New York.

Abstract Lymphangioleiomyomatosis (LAM), is a rare cause of diffuse cystic lung disease and primarily involves premenopausal female population. It is seen sporadic or in association with complex. High resolution computed tomography (HRCT) usually establishes the diagnosis in patient with typical findings of thin walled with normal lung parenchyma in between. Surgical lung is needed only in cases with high suspicion and minimal findings on HRCT.

Introduction to thoracic unit for chest tube care and pain control. Chest x ray obtained in subsequent 2nd and 3rd days Here, we describe a case of LAM in a young female showed persistent and air leak in who presented for spontaneous pneumothorax. chest tube. On 4th day of admission she underwent Due to persistent air leak, post tube thoracostomy VATS guided mechanical along with right she underwent VATS (video assisted thoracoscopic upper lobe wedge rejection. Gross examination of the surgery) guided exploration with lung biopsy. ted lung during VATS was reported as having Histopathological diagnosis of emphysematous lung multiple sub pleural blebs. Post-surgery she was was given. She then underwent CT scan and second affec observed for 3 more days with the chest tube in place. opinion from pathology, both of which were consistent Histopathology reading of the biopsy specimen came with LAM. back as “emphysematous changes of air spaces”. On 7th Case day, she was discharged. A week post discharge, she visited pulmonary clinic where she had a CT scan of history presented for threedays’ history of constant her chest. CT scan chest was reported to have multiple 33-year-old female with no significant past medical sharp right sided chest pain associated with . On presentation to emergency 3). The biopsyspecimen was sent for second opinion ill-defined cysts throughout the lung parenchyma (fig department, a chest x ray was done which showed a large right pneumothorax (Fig 1). A 12 Fr pigtail multiple cysts lined by spindle cells with Immuno to different facility. Pathology report came back as catheter was inserted and connected to suction. X histochemical stain positive for HMB 45. Morphology ray obtained 4 hours later showed improvement on and immune phenotype supported diagnosis of size of the pneumothorax (Fig 2). She was admitted lymphangioleiomyomatosis (LAM) Archives of Pulmonology and Respiratory Medicine V2 . I1 . 2019 7 A Case of Lymphangioleiomyomatosis and Review of Literature

Fig 1. large right side pneumothorax

Fig 2. right side chest tube with resolution of pneumothorax.

Fig 3. CT scan showing diffuse thin walled cysts. 8 Archives of Pulmonology and Respiratory Medicine V2 . I1. 2019 A Case of Lymphangioleiomyomatosis and Review of Literature Description Very few cases of LAM have been reported by far. Lymphangioleiomyomatosis (LAM) is a rare disease lung biopsy proven LAM. Most common symptoms includedRobert H. shortness Sherrieret of al breath reported in 5 patients,8 women dyspnea with open on seen in women of childbearing age, it is characterized affecting less than one in one million people. Typically exertion in 3 patients, abdominal pain and swelling in 2 and pneumothorax in 2 patients. Daniel C. Rappaport lungs, extra thoracic organs and . by a typical smooth muscle proliferation affecting et al reported 4 patients and all of them presented with disease leading to distortion of architecture, cystic shortness of breath, 2 had recurrent pneumothoraces, emphysema,Cystic lung lesions and progressive are most common deterioration finding of of lung the function. It can also manifest in abdomen as abdominal 1 patient had recurrent episodes of . Yuen- 1 patient had recurrent chylous pleural effusions and tumors known as which usually Yee Wong et al reported a patient who presented with right lower quadrant abdominal pain and fever. CT revealed multiple thin walled pulmonary cysts and twoaffects types the of subpopulations:kidneys [1]. Microscopically, small spindle the shaped affected an encapsulated mass in the retroperitoneum which organs are in filtrated with LAM cells, which include was compatible with lymphangioleiomyomatosis and , and ; and epithelioid like cells retroperitoneal . cells expressing smooth muscle specific , expressing markers of melanoma cells and immature Given the rarity of the disease and variable clinical course the prognosis of LAM is unclear. It usually melanocytesLAM can be like sporadic MelanA/Mart1 or can and be gp100. associated [2]. with progresses slowly with a median survival more than Tuberous Sclerosis Complex (TSC). The latter is an autosomal dominant syndrome, characterized by and death. is the standard treatment8 years from of diagnosis lymphangioleiomyomatosis, leading to respiratory but failure it can recur in transplanted lungs. and , mental retardation, , cerebral calcifications mTORC1 inhibitors inhibit growth and proliferation of andPatien hamartomatousts most commonly lesions in present several organs with dysp [3]. nea (70%), and less commonly with chest pain, cough, LAM cells by targeting the mTOR activated signaling wheezi ommon presentat ion, caused function by slowing decline in FEV1 and DLCO when pathway. [9] Treatment with sirolimus stabilized lung by ruptureng and or hemoptysis. obstructed lymphatic[4, 5, 6]. Less vessels c and spontaneousions pnemothoprax are Chylous pleuralas in our effus patient. Involve guidelines recommended treatment of patients with used for a period of 3.5 years. [10]. Recent ATS/JRS ment of axial lymphatics may lead to formation of abnormal lung function, that is FEV1 less than 70% of predicted or declining lung function with sirolimus. ctures within the chest and abdomen. Very rarely It is also recommended in patients with symptomatic lymphangioleiomyomas, chyle-filled lymphatic stru from angiomyolipomasof . considered. (11) patients present solely with flank pain or hematuria chylous fluid effusions before invasive procedures are Diagnosis is made with radiographic studies, Reference lung function tests and/ or surgical removal and

What do we know and what are we looking for? of thin walled cysts throughout the lung on high [1] Harari S, Torre O, Moss J. Lymphangiomyomatosis: resolutionmicroscopic CT study (HRCT), of the is affected the most tissue. diagnostic The presencefeature EurRespir Rev 2011; 20: 34-44. then a surgical biopsy is done. Abnormal proliferation cell proliferation and expression of melanosomal of LAM. [5, 7, 8]. If HRCT findings are non-diagnostic, of smooth muscle cells (LAM cells) along with [2] antigenMatsumoto in. Y, Horiba K, Usuki J, et al. Markers of examination. Pulmonary Function Test (PFT) is used Franz DN, Brody A, Meyer C et al. Mutational tocystic assess changes disease confirms progression the disease and severity on histologic of LAM, and radiographic analysis of pulmonary disease [3] although it can be normal in upto 30% of the patients. consistent with lymphangioleiomyomatosis and equently micronodularpneumocyte in women

[7, 8]. Functional abnormalities most fr observed are airflow obstruction and decreased lung with tuberous sclerosis. Am J RespirCrit Care Archives of Pulmonology and Respiratory Medicine V2 . I1 . 2019 9 diffusion capacity. Med 2001; 164: 661-666. A Case of Lymphangioleiomyomatosis and Review of Literature of qualitative and quantitative thin section CT with pulmonary fuction tests and assessment [4] lymphangioleiomyomatosis. Am J Respir Cell Mol of dependence on pleurodesis. Radiology 2002; BiolZhe X,1999; Schuger 21: 327-336. L. Combined smooth muscle and [5] myomat 52: 223:Krymskaya 189-197. VP, Goncharova EA. PI3K/mTORC1 1537-1542.melanocytic differentiation in lymphangioleio activation in hamartoma syndromes: therapeutic osis. J Histochemcytochem 2004; [10] Ryu BI lymphangioleiomyomatosis registry: characteri prospects. Cell Cycle 2009; 8: 403-413. [6] JH, Moss J, Beck GJ, et al. The NHL [11] cysticYao J, lung Traveira-DaSilva lesions in lymphangioleiomyomatosis. AM, Jones AM, et al. stics of 230 patients at enrollment. Am J Respir ASustained effects of sirolimus on lung function and Crit Care Med 2006; 173: 105- 111. . clinical picture of lymphangioleiomyomatosis. m J RespirCrit Care Med 2014; 190: 1273 - [7] Cohen MM, Pollock-Barziv S, Johnson SR. Emerging 1282McCormack FX, Gupta N, Finlay GR, et al. McCormack FX. Lymphangioleiomyomatosis: a Thorax 2005; 60: 875-879. [12] Respiratory Society Clinical Practice Guidelines: Official American Thoracic Society/Japanese [8] Lymphangioleiomyomatosis Diagnosis and Mana clinical update. Chest 2008; 133: 507-516.

[9] Avila NA, Dwyer AJ, Murphy- Johnson DV, Brooks P, gement. Am J RespirCrit Care Med 2016; 194: Moss J. Lymphangioleiomyomatosis: correlation 748-761.

Citation: Dikshya Sharma, Bindumudduluru, Michel Chalhoub. A Case of Lymphangioleiomyomatosis and Review of Literature. Archives of Pulmonology and Respiratory Medicine. 2019; 2(1): 07-10. Copyright: © 2019 Dikshya Sharma, Bindumudduluru, Michel Chalhoub. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

10 Archives of Pulmonology and Respiratory Medicine V2 . I1. 2019